Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$22.1B
sum of reported positions
Reported positions
660
Changes vs prior quarter
624
41 new · 54 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 354 measured positions in 8 quarters, the typical new or larger position finished +0.0 pts against the S&P 500 and 50% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $19.2B | $22.1B |
| Positions | 673 | 660 |
| Biggest line | — | NVIDIA 6% |
| 2.62M |
| $936M |
| 4.2% |
| 1.69M | $639M | 2.9% |
| 2.6M | $618M | 2.8% |
| 423K | $488M | 2.2% |
| 402K | $482M | 2.2% |
| 658K | $382M | 1.7% |
| 963K | $328M | 1.5% |
| 713K | $309M | 1.4% |
| 843K | $297M | 1.3% |
| 1.16M | $293M | 1.3% |
| 606K | $289M | 1.3% |
| 761K | $229M | 1.0% |
| 644K | $221M | 1.0% |
| 379K | $194M | 0.9% |
| 1.42M | $182M | 0.8% |
| 1.35M | $179M | 0.8% |
| 544K | $178M | 0.8% |
| 2.01M | $176M | 0.8% |
| 347K | $174M | 0.8% |
| 429K | $171M | 0.8% |
| 210K | $159M | 0.7% |
| 271K | $152M | 0.7% |
Kymera Therapeutics (KYMR)
202K → 193K shares (−4%)
Oracle (ORCL)
144K → 150K shares (+4%)
Moderna (MRNA)
231K → 309K shares (+34%)
CBRE Group (CBRE)
168K → 160K shares (−5%)
First Solar (FSLR)
103K → 91K shares (−12%)
Synopsys (SNPS)
73K → 48K shares (−35%)
Astera Labs (ALAB)
36K → 43K shares (+21%)
Manulife Financial (MFC)
571K → 504K shares (−12%)
Arcus Biosciences, Inc. (RCUS)
791K → 662K shares (−16%)
Praxis Precision Medicines (PRAX)
64K → 61K shares (−4%)
Vera Therapeutics (VERA)
475K → 468K shares (−2%)
Dianthus Therapeutics, Inc. (DNTH)
214K → 204K shares (−4%)
Deckers Brands (DECK)
118K → 200K shares (+69%)
Targa Resources (TRGP)
159K → 72K shares (−54%)
Chemed Corp. (CHE)
43K → 41K shares (−4%)
Verizon (VZ)
520K → 455K shares (−13%)
Abbott Laboratories (ABT)
624K → 211K shares (−66%)
Alibaba Group Holding (BABA)
565K → 199K shares (−65%)
Owens Corning (OC)
76K → 119K shares (+57%)
W. P. Carey (WPC)
537K → 264K shares (−51%)
TEVA PHARMACEUTICAL INDS LTD
468K → 551K shares (+18%)
Incyte (INCY)
342K → 163K shares (−52%)
Cheniere Energy (LNG)
92K → 77K shares (−17%)
Idexx Laboratories (IDXX)
64K → 35K shares (−46%)
Compass Pathways (CMPS)
1.27M shares
